| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.0000224117.59417.F3 |
| P698 | PubMed publication ID | 16645141 |
| P50 | author | Norifumi Urao | Q54186237 |
| Tetsuya Nomura | Q76364541 | ||
| P2093 | author name string | Hiroaki Matsubara | |
| Tomosaburo Takahashi | |||
| Hiroyuki Yamada | |||
| Mitsuhiko Okigaki | |||
| Tetsuya Tatsumi | |||
| Akihiro Matsui | |||
| Shinsaku Matsunaga | |||
| Kento Tateishi | |||
| Kuniharu Matsuno | |||
| Yasushi Aadachi | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1405-1413 | |
| P577 | publication date | 2006-04-27 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia | |
| P478 | volume | 98 |
| Q36943965 | Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells |
| Q91386840 | Activation of heme oxygenase-1 by Ginkgo biloba extract differentially modulates endothelial and smooth muscle-like progenitor cells for vascular repair |
| Q36720543 | Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors |
| Q36694644 | Acute erythropoietin cardioprotection is mediated by endothelial response. |
| Q38720387 | Acute-on-chronic liver failure: terminology, mechanisms and management |
| Q36112416 | Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells |
| Q37207783 | Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo |
| Q37533151 | Cardiovascular effects of erythropoietin an update |
| Q41813965 | Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity. |
| Q37879584 | Cell-based therapies for diabetic retinopathy |
| Q34479931 | Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial |
| Q37589340 | Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice |
| Q28750073 | Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy |
| Q40235078 | EPO tecting the endothelium |
| Q36256384 | Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trial |
| Q33726150 | Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial |
| Q37290687 | Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside |
| Q43987732 | Endothelial cells (EC) and endothelial precursor cells (EPC) kinetics in hematological patients undergoing chemotherapy or autologous stem cell transplantation (ASCT). |
| Q49989369 | Endothelial nitric oxide synthase overexpressing human early outgrowth cells inhibit coronary artery smooth muscle cell migration through paracrine functions. |
| Q28303395 | Endothelial progenitor cells: identity defined? |
| Q37781871 | Erythropoietin 2nd cerebral protection after acute injuries: A double-edged sword? |
| Q26750850 | Erythropoietin Pathway: A Potential Target for the Treatment of Depression |
| Q41261940 | Erythropoietin Stimulates Endothelial Progenitor Cells to Induce Endothelialization in an Aneurysm Neck After Coil Embolization by Modulating Vascular Endothelial Growth Factor |
| Q40491658 | Erythropoietin and Soluble Erythropoietin Receptor: A Role for Maternal Vascular Adaptation to High-Altitude Pregnancy |
| Q35146283 | Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress |
| Q38637551 | Erythropoietin for the treatment of subarachnoid hemorrhage: A feasible ingredient for a successful medical recipe |
| Q35909929 | Erythropoietin in brain development and beyond |
| Q37109255 | Erythropoietin in heart and vessels: focus on transcription and signalling pathways |
| Q42154729 | Erythropoietin in the critically ill: do we ask the right questions? |
| Q37107596 | Erythropoietin increases endothelial biosynthesis of tetrahydrobiopterin by activation of protein kinase B alpha/Akt1. |
| Q33857619 | Erythropoietin increases expression and function of vascular copper- and zinc-containing superoxide dismutase |
| Q35950357 | Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity |
| Q34668310 | Erythropoietin prevents endothelial dysfunction in GTP-cyclohydrolase I-deficient hph1 mice |
| Q42916923 | Erythropoietin prevents vascular inflammation and oxidative stress in subtotal nephrectomized rat aorta beyond haematopoiesis |
| Q37326950 | Erythropoietin signaling promotes transplanted progenitor cell survival |
| Q33492716 | Erythropoietin sustains cognitive function and brain volume after neonatal stroke |
| Q36516298 | Erythropoietin update 2011 |
| Q57701924 | Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury |
| Q36974229 | Erythropoietin, progenitors, and repair |
| Q37952603 | Erythropoietin: a future therapy for failing hearts? |
| Q42972651 | Erythropoietin: when liability becomes asset in neurovascular repair |
| Q45871409 | Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model |
| Q38552119 | Growth factors enhance liver regeneration in acute-on-chronic liver failure |
| Q46003079 | Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients. |
| Q83749924 | Implication of AMP-activated protein kinase in transient receptor potential vanilloid type 1-mediated activation of endothelial nitric oxide synthase |
| Q34718887 | Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration |
| Q46977348 | Natural compound bavachalcone promotes the differentiation of endothelial progenitor cells and neovascularization through the RORα-erythropoietin-AMPK axis |
| Q37696218 | Nitric oxide and hypoxia stimulate erythropoietin receptor via MAPK kinase in endothelial cells |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q52763616 | Novel molecular targets for coronary angiogenesis and ischemic heart disease. |
| Q28580309 | Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury |
| Q35070827 | Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells |
| Q41055689 | Novel zinc finger transcription factor ZFP580 promotes differentiation of bone marrow-derived endothelial progenitor cells into endothelial cells via eNOS/NO pathway |
| Q39148627 | Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality. |
| Q37053167 | Progenitor cells and vascular disease |
| Q33776274 | Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells |
| Q28482627 | Rapamycin regulates the expression and activity of Krüppel-like transcription factor 2 in human umbilical vein endothelial cells |
| Q35669620 | Recent concepts for the roles of progenitor/stem cell niche in heart repair. |
| Q38078140 | Restoring stem cell mobilization to promote vascular repair in diabetes. |
| Q36153802 | Role of erythropoietin in the brain |
| Q42756513 | Saphenous Vein Graft Disease Is Associated with a Low Serum Erythropoietin Level |
| Q52352341 | Shear stress: An essential driver of endothelial progenitor cells. |
| Q36599286 | Stem cell recruitment after injury: lessons for regenerative medicine |
| Q38603660 | Stem cell therapies in the treatment of diabetic retinopathy and keratopathy |
| Q34725972 | Survival and proliferative roles of erythropoietin beyond the erythroid lineage |
| Q24642914 | Switching on reparative angiogenesis: essential role of the vascular erythropoietin receptor |
| Q35224135 | Systemic administration of erythropoietin inhibits retinopathy in RCS rats |
| Q34475689 | Targeting stem cell niches and trafficking for cardiovascular therapy |
| Q42315498 | Tetrahydrobiopterin determines vascular remodeling through enhanced endothelial cell survival and regeneration |
| Q38123004 | The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection. |
| Q36002875 | The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection. |
| Q37195742 | The role of erythropoietin as an inhibitor of tissue ischemia |
| Q37478093 | The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma. |
| Q36915712 | Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. |
| Q37182044 | Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling |
| Q36612448 | Vulnerable plaque: from bench to bedside; local pacification versus systemic therapy |
| Q83739181 | [Perspectives of regenerative mechanisms in cardiovascular disease spotlighting endothelial progenitor cells] |
Search more.